Molecular Partners Unveils Promising Preclinical Data on Radio-DARPin Programs at AACR 2025
Molecular Partners AG presented new preclinical data at AACR 2025, showcasing advancements in its Radio-DARPin and Switch-DARPin programs, particularly in oncology, with clinical trials set to commence in 2025.
2 minutes to read